Sarah Korman, PhD JD is General Counsel at Isomorphic Labs, an autonomous subsidiary of Alphabet that was launched from Alphabet’s DeepMind in 2021 to build on the success of AlphaFold, the company’s groundbreaking work in protein folding. Sarah was most recently Chief Legal Officer at Absci, a generative AI drug creation company focused on biologics. She was previously General Counsel at Neuvogen and held roles specializing in intellectual property at Amgen, Onyx Pharmaceuticals and the World Intellectual Property Organization. She started her legal career in private practice. Sarah earned dual undergraduate degrees in chemistry and metallurgical/materials engineering from South Dakota Mines, a PhD in materials science and engineering from The Pennsylvania State University, and her Juris Doctorate from DePaul University College of Law. She is a National Science Foundation Fellow and an inventor on various patents directed to nano-enabled therapeutics and drug delivery technologies.